BIOQ OTC
Bioqual, Inc.
1W: +0.0%
1M: +0.0%
3M: +1.5%
YTD: -14.3%
1Y: -17.5%
3Y: -44.1%
5Y: -59.2%
$33.00
+0.00 (+0.00%)
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$49M
-16.6% ▼
5Y CAGR: +1.1%
Gross Profit
-$2M
-125.5% ▼
Operating Income
-$2M
-9554.8% ▼
Net Income
-$1M
-316.8% ▼
EPS (Diluted)
$-1.17
-316.7% ▼
EBITDA
$510K
-83.2% ▼
5Y CAGR: -44.6%
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $58M | $66M | $63M | $59M | $49M |
| YoY Growth | +24.4% | +14.7% | -5.3% | -6.5% | -16.6% |
| Cost of Revenue | $44M | $53M | $50M | $51M | $51M |
| Gross Profit | $14M | $13M | $13M | $7M | -$2M |
| Gross Margin | 24.2% | 19.7% | 20.1% | 12.7% | -3.9% |
| R&D Expenses | $829K | $1M | $806K | $0 | $0 |
| SG&A Expenses | $5M | $5M | $12M | $7M | $0 |
| Operating Expenses | $5M | $6M | $11M | $7M | $6M |
| Operating Income | $9M | $7M | $1M | -$20K | -$2M |
| Operating Margin | 14.8% | 9.9% | 1.8% | -0.0% | -3.9% |
| Interest Expense | $0 | $0 | $0 | $0 | $0 |
| Income Before Tax | $9M | $7M | $1M | $476K | -$1M |
| Tax Expense | $2M | $1M | $298K | -$7K | -$238K |
| Net Income | $6M | $5M | $836K | $483K | -$1M |
| Net Margin | 11.0% | 8.0% | 1.3% | 0.8% | -2.1% |
| EPS (Diluted) | $7.08 | $5.88 | $0.93 | $0.54 | $-1.17 |
| EBITDA | $13M | $15M | $7M | $3M | $510K |
| Shares Outstanding | 894054 | 894423 | 894416 | 894416 | 894416 |